One biotech is looking to lessen antipsychotic-induced weight gain, despite new entrants

Response Pharmaceuticals believes its experimental drug can lessen the persistent weight gain associated with antipsychotics. In a new pilot study, the company assessed RDX-002 in 20 healthy people. After a week of participants taking olanzapine ...